We present three cases that reveal the local view of the social value of health research for Ugandans: autonomy and consent; the concept of risk; and what appears to be a classic case of therapeutic misconception between researcher and informant.
Of course, it should be emphasized that possible disease control after discontinuation of biological anti-rheumatic drugs is still shown only in preliminary trials, and it should not be used for patients without sufficient informed consent of the risk of worsened outcome.
These findings highlight the importance for proper informed consent of the potential risk and impact of OIEARR.
Second, by consideration of Daniels' argument that by freely joining a profession designed to combat disease, one consents to some standard of risk, and third, by realizing that the profession has flourished due to socially negotiated promises to be available in such times of duress".
The consensus regarding the research policy of the ICF template for MGSP applicants consisted of the following five key issues (Table 1): research purpose; collaboration with external institutes; data sharing; withdrawal of consent; and risk assessment and management.
Inclusion criteria: Women, giving informed consent, at risk of preterm birth between 30 to 34 weeks' gestation, where birth is planned or definitely expected within 24 hours, with a singleton or twin pregnancy and no contraindications to the use of magnesium sulphate.
Institutional review boards (IRBs) typically apply common rules and regulations to protect human research subjects, in accordance with Title 45 § 46 of the US Code of Federal Regulations (45 C.F.R. § 46) regarding informed consent process, balance of risks and benefits, protection of participant privacy, and other requirements for the approval of proposed research.
A third approach is to base risk acceptance on the consent of people who suffer the risks after they have been informed about these risks (informed consent).
However, informed consent of acute organophosphate poisoning risk and all treatment modalities (including cardiopulmonary cerebral resuscitation, etc).
If it is determined that privacy concerns necessitate designation of family members as human participants, then investigators need to either address these issues in the human subjects protection procedures submitted to their IRBs (e.g., informed consent; minimizing risks of disclosure of confidential information) or modify data collection procedures to ensure privacy protections.
